EDRH
VKTX icon

Edmond de Rothschild Holding’s Viking Therapeutics VKTX Stock Holding History

Edmond de Rothschild Holding’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,000
Closed -$32.5K – 646
2026
Q1 		$32.5K Hold
1,000
– – ﹤0.01% 468
2025
Q4 		$35.2K Hold
1,000
– – ﹤0.01% 481
2025
Q3 		$26.3K Hold
1,000
– – ﹤0.01% 500
2025
Q2 		$26.5K Hold
1,000
– – ﹤0.01% 492
2025
Q1 		$24.1K Buy
1,000
+500
+100% +$15.8K ﹤0.01% 504
2024
Q4 		$20.1K Hold
500
– – ﹤0.01% 548
2024
Q3 		$31.7K Hold
500
– – ﹤0.01% 558
2024
Q2 		$26.5K Buy
+500
New +$32.8K ﹤0.01% 599

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Edmond de Rothschild Holding's VKTX Position: Q2 2026 in Review

Edmond de Rothschild Holding sold out of Viking Therapeutics (VKTX) in Q2 2026, closing a stake of 1,000 shares — an estimated $32.5K sold.

Edmond de Rothschild Holding first reported a position in VKTX in Q2 2024 and held it in 8 quarters. The position peaked at $35.2K in Q4 2025. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Edmond de Rothschild Holding reported no remaining Viking Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 1,000 Viking Therapeutics shares in Q2 2026, an estimated $32.5K.
  • Edmond de Rothschild Holding first reported a position in Viking Therapeutics in Q2 2024 and held it in 8 quarters.
  • Edmond de Rothschild Holding's Viking Therapeutics position peaked at $35.2K in Q4 2025.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.